Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Thorne Research (THRN)

Thorne HealthTech relies on an autonomous development cycle, establishing the company as a stable defensive asset regardless of macroeconomic conditions. AI platforms and contracts with US leagues in the digital health segment provide a competitive advantage, while high product purity ensures athlete loyalty. The recorded quarterly EPS dynamics illustrate the depth of the drawdowns, where the value of 0.00 serves as the current metric.

Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan thorne.com (THRN): kanggo periode 04.07.2022 - 21.10.2023

Thorne Research (THRN) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Bagan rega Thorne HealthTech, Inc.|THRN - Rata-rata rega prakiraan

- rincian kapitalisasi pasar:

Nilai pasar Thorne|THRN - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Thorne HealthTech|THRN - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku thorne.com|THRN - Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- rincian bathi lan kelipatan pasar:

THRN - Bathi resik perusahaan|Bathi mangsa ngarep Thorne HealthTech|THRN - Rasio rega pasar marang bathi resik|Pangali Forward P/E Thorne|THRN - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Thorne|THRN - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Thorne HealthTech|THRN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan thorne.com|THRN - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Thorne HealthTech

Ringkesan analitik perusahaan:Thorne HealthTech, Inc. - THRN

The monetization of the personalized nutraceuticals digital ecosystem of Thorne HealthTech (THRN) through subscriptions and AI testing translates directly into shareholder value. The current quarterly EPS growth rate of 0.00 measures the efficiency of converting macroeconomic recovery into net income per share, allowing investors to distinguish sustainable business growth from temporary peaks prior to a market cooling phase.

Analisis perusahaan pesaing

Hims & Hers (HIMS) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Hinge Health, Inc. (HNGE)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Teladoc Inc.|TALK: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan LifeMD, Inc. (LFMD)|amwell.com - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan MGRX (Mangoceuticals)|DarioHealth Corp (DRIO) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|VSEE: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan MNDR (Mobile-health Corp)|ACCD: Wutah bathi EPS kuartalan|biotricity.com - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|LYT (Lytus Technologies Holdings) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Ontrak Inc OTRK|Wutah bathi EPS kuartalan SHLT